Your web browser is out of date! We recommend you update your browser to receive the best possible browsing experience.
Download your Brochure
Reserve your place

Content Hub

Decoding Digital Medicine With the approval of the first ‘digital medicine’ last year, a new digital wave is hitting pharma. What does it look like and how transformative is its potential?

Pharma's Moment To Shine President of Lilly Bio-Medicines, Christi Shaw, shares her personal experience of the US Healthcare system and how it changed her perspective on pharma’s road ahead

Zooming In On Patient-Centricity We talk with Bob Oliver, President & CEO, V ClinBio, ahead of his Keynote talk at Philadelphia 2018, about how to overcome the internal and external hurdles associated with patient centricity.

The New Normal Fabrice Chouraqui, President U.S., Novartis outlines his vision of a ‘new dawn’ for the pharma industry, speaking of a need for creating greater value and more transparency for patients and caregivers. Fabrice will be continuing this theme during his Keynote talk at Philadelphia 2018, where he will be part of a panel all about ‘Value’ and what that looks like to different stakeholders.

Carers: The Forgotten Heroes of Healthcare Scott Williams, VP, Head of Global Patient Advocacy & Strategic Partnerships, highlights the importance of carers in the patient journey.

The Death Of The Brand Markus Leyck Dieken, SVP, Teva, speaks to us about how pharma is moving from brand-centricity to the customer-centric age of greater personalization and objectivity, dubbing it the ‘democratization of healthcare’.

Best of Both Worlds We ask the question ‘can pharma deliver both patient value and shareholder value?’ in this recent eyeforpharma article, with insights from Pfizer, Merck, AstraZeneca and GSK.

PSPs: Avoiding the Pitfalls Delivering effective patient support programs (PSPs) is rapidly becoming an essential component of patient access but there are many pitfalls to avoid

Four Reasons Why Pharma Struggles To Engage HCPs Online (And How To Change That) We talk with Sanofi’s Global Head of Digital Medicines, Bozidar Jovecevic, ahead of his talk at Philadelphia 2018 on how pharma can improve their engagement with physicians online.

How Pfizer Rare Disease are differentiating themselves We sat down with Tolga Tanguler, President North America, Pfizer Rare Diseases ahead of his talk at Philadelphia 2018 on how Pfizer Rare Disease are differentiating themselves with a patient-centric culture.

We must join together to restore trust Kabir Nath, President, Otsuka, US speaking about why he decided to speak at eyeforpharma Philadelphia.

Fly On The Wall In “Fly on the Wall”, we explore the benefits of social listening, including addressing adherence issues and improving the effectiveness of patient support programs, with insights from experts in this space including the President & CEO at Amplyx Pharmaceuticals; a Senior Consultant at QuintilesIMS and a Patient Advocate and Social Media Expert.

The Sales Survival Guide Whilst large field-based sales forces used to be a sign of Pharma’s immense power and influence in the U.S., recently the focus has shifted from quantity to quality of interactions, with leaner and more agile teams with a stronger customer focus. In our latest article, ‘Sales Survival Guide’, we spoke to experts in the space from GSK, AMAG Pharmaceuticals, Merck Sharp & Dohme and Novartis, to ask them how they’re creating more valuable customer interactions

Pharma Collaborations: Critical factors for success Melinda Richter, Head of Jlabs and Dalvir Gill, CEO of TransCelerate speaking at eyeforpharma Philadelphia about how to make pharma collaborations work.

Marc Boutin: Look at what we have achieved. Marc Boutin, CEO, The National Health Council speaking at eyeforpharma Philadelphia and congratulating the 600+ attendees in the room, for the progress that has been made in being patient-centricity over the last 7 years

How does Kaiser Permanente define value? Andy McCulloch, President, Kaiser Foundation Health Plan/Hospitals, Northwest Region speaking at eyeforpharma Philadephia about how Kaiser defines value.

Uncertainty in US healthcare Andy McCulloch, President, Kaiser Foundation Health Plan/Hospitals, Northwest Region and Marc Boutin, CEO of The National Health Council speaking at eyeforpharma Philadelphia on how US healthcare is in a state of uncertainty.

Kabir Nath: Patient solutions need to be lifestyle solutions Kabir Nath, President, Otsuka USA speaking at eyeforpharma Philadelphia about how to create solutions for patients, we first need to understand their lifestyle and the environment they live in.

Act like SARS and go viral with patient-centricity Julie Gerberding, EVP and Chief Patient Officer at Merck, speaking at eyeforpharma Philadelphia on how in order to create change in an organization, you need to go viral.


Don’t miss out on Philadelphia 2018

If you are interested in getting involved in eyeforpharma Philadelphia, please contact us on the details below.

Josh Bramwell

Josh Bramwell

Global Project Director
eyeforpharma

Phone: +44 (0) 207 375 7203

Email: jbramwell@eyeforpharma.com

Izzy Gladstone

Izzy Gladstone

Head of Marketing
eyeforpharma

Cell: +1 347 458 1621

Email: igladstone@eyeforpharma.com